Anthropic says Claude is now working on drug development with six companies and on its own rare childhood disease programmes

Anthropic published an update on its life sciences work. Over several months it has worked with six organisations developing medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group. It has also begun its own discovery programmes, including for rare childhood forms of muscular dystrophy, where Claude handles much of the scientific and operational work.

• Nothing changes for you today, and this is not a medical product. Keep asking your doctor or pharmacist, not an AI chat, about your own treatment.
• If you run a health, lab or care business, note that the post lists tasks AI is helping with, from early research to drafting regulatory filings.

Source: Anthropic. This is our short summary of their reporting. The paragraphs marked "Our read" and the things to do are SeedFoundry's opinion. The summary is drafted with AI tools. Image: Anthropic, from its own announcement. How we source and credit